SHZ · 000963.SZ
Huadong Medicine Co., Ltd
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
Loading market information…
SHZ · 000739.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Apeloa Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.44% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Apeloa Pharmaceutical Co.,Ltd’s forward annual dividend is CN¥0.28 per share, paid semi-annual. The forward yield is 1.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Apeloa Pharmaceutical Co.,Ltd’s next earnings report is currently expected on Mar 5, 2027, with estimated earnings per share of CN¥0.45. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Apeloa Pharmaceutical Co.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:16 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Aug 19, 2025 | CN¥0.27-15.62% vs estimate | CN¥2.71B0.0% vs estimate |
|---|
| Q1 2025 | Apr 17, 2025 | CN¥0.21-38.24% vs estimate | CN¥2.73B |
|---|
| Q4 2024 | Mar 10, 2025 | CN¥0.14-53.33% vs estimate | CN¥2.73B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥16.43+CN¥0.53 (+3.33%)
Zhejiang Huahai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.18% below the high.
CN¥21.59+CN¥0.39 (+1.84%)
Jiangsu Nhwa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.99% below the high.
CN¥23.67+CN¥0.04 (+0.17%)
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.93% below the high.
CN¥15.19+CN¥0.60 (+4.11%)
Shandong Buchang Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.76% below the high.
CN¥13.23+CN¥0.51 (+4.01%)
Zhejiang Hisun Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 11.8% below the high.
CN¥73.80+CN¥0.75 (+1.03%)
Fujian Cosunter Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.47% below the high.
CN¥11.99+CN¥0.20 (+1.7%)
Beijing Aosaikang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.53% below the high.
